Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA proposes ending use of popular decongestant present in cold medicines
The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.
FDA to pull common but ineffective cold medicine from market
The agency's proposed order would remove oral phenylephrine from the "monograph" of ingredients that drugmakers are allowed to use in cough and cold medicines which are sold on store shelves without a
prescription
... the inhaled
nasal
spray
versions ...
FDA Wants to Ban Popular But Ineffective Cold Remedy Ingredient
The agency made the proposal after finding that the ingredient, known as oral phenylephrine, doesn’t relieve stuffy noses.
FDA proposes removing ineffective decongestant found in most cold medicine
The Food and Drug Administration (FDA) is proposing to remove from the market a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work. The move brings FDA one step closer to getting products containing oral phenylephrine pulled from stores.
1d
Urgent warning to millions who use popular over-the-counter cold and flu remedy that could ‘worsen breathing’
AS COLD and flu season hits, a GP has issued a warning over a common remedy that could cause symptoms to “come back with a ...
Yahoo Finance
12h
Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
Nov. 07, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on ...
Couriermail
10d
‘One on every corner, like 7-11’: Aussies flout rules for ‘sexy’ quest
and illegal to supply them without a doctors’
prescription
. “So I did it, just to get a free
nasal
spray
,” Jessika says of the #sponcon posts. Medical organisations around the world warn the ...
WESA
10d
Pittsburgh harm reduction experts: stronger overdose reversal drugs aren't better
Overdose reversal drugs could play a major role in continuing a downward trend of fatal opioid overdoses. But some harm ...
2d
Aquestive: Rare Opportunity With Dual Platform Strategy
The Adrenaverse platform is a relatively new platform by Aquestive. This platform is essentially the 'secret-sauce' ...
10d
Evoke Pharma Stock Is Soaring Monday: What's Going On?
Evoke Pharma Inc (NASDAQ:EVOK) shares are trading higher Monday after the company presented GLP-1 data for users with ...
Stockhead on MSN
9d
ASX Quarterly Health Wrap: Lift-off for ED nasal spray and record users for pregnancy-monitoring platform
HeraMED, Lumos Diagnostics and LTR Pharma are among ASX health companies reporting strong quarterly results this week.
10d
Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
Analysis of real-world data compared patients on GIMOTI (n=51) to Oral Metoclopramide (n=41), both taking GLP-1s, showing ...
11h
on MSN
Nasal spray made from stem cell-derived vesicles could treat Alzheimer's disease
A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback